SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors eagerly anticipate earnings, with many hoping for a strong report to push the stock higher. Community discussions revolve around potential S&P 500 inclusion and the impact of future interest rate cuts on the fintech company. Bullish sentiment is high, with some comparing SoFi to other disruptive tech stocks.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph ($HBAR) is trending as the community anticipates the launch of a Canary HBAR ETF, potentially bringing institutional investment and increased liquidity to the crypto. The potential ETF listing is fueling excitement, with many viewing it as validation of Hedera's enterprise-grade technology and a significant step towards mainstream adoption.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as investors discuss the company's recent capital raise and its potential impact on funding the launch of its satellites for global 5G coverage; the community is analyzing upcoming earnings and potential military applications, while debating the stock's valuation and future prospects amid competition in the satellite connectivity sector.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

GLXY is trending due to a recently announced $1 billion private offering of exchangeable senior notes, leading to concerns about potential dilution despite a strong earnings report. The community is debating whether this is a strategic move to fuel growth in AI/data centers or a sign of financial strain. Discussions also involve the broader context of crypto treasuries and comparisons to similar offerings from other companies.

Columbus Circle Capital Corp. I operates as a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which refer to throughout this prospectus as initial business combination. The company was founded in June 2024 and is headquartered in New York, NY.

Columbus Circle Capital Corp I - Ordinary Shares - Class A

The stock is trending due to excitement around Eric Jackson joining the board, with speculation that Mike Alfred may join as well, leading to comparisons to previous plays like $ASST. The community is focused on the low-priced call options and the potential for a gamma squeeze, anticipating significant gains.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as investors weigh the potential impact of restructuring efforts and upcoming earnings, with community members discussing dividend sustainability and volume concerns. Some traders express optimism based on after-hours activity and potential for a holiday season boost, while others fear a dividend cut and continued struggles with profitability. The stock's valuation and potential takeover scenarios are also circulating as talking points.

An AI x Metaverse Protocol that is building the future of virtual interactions.

Virtual Protocol

Virtual Protocol is trending as community members discuss its potential, comparing it to past crypto successes while navigating price volatility. Bullish sentiment focuses on the project's AI agent technology and the broader AI narrative, while some traders are actively capitalizing on price swings. The conversation also includes discussions of potential listings and ecosystem developments.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending due to a significant price drop triggered by a temporary halt in late-stage trials following a patient hospitalization, sparking concerns about the safety of their leading drug candidate, nex-z. Despite the setback, some investors view the over 40% decline as a buying opportunity, while others speculate on potential risk mitigation strategies and the broader implications for gene-editing technologies; Cathie Wood's continued buying of NTLA shares adds to the discussion.

Rambus, Inc. engages in the provision of cutting-edge semiconductor and Internet Protocol products, spanning memory and interfaces to security, smart sensors and lighting. Its products include Memory Interface Chips, Interface IP, and Security IP. The company was founded by P. Michael Farmwald and Mark A. Horowitz in March 1990 and is headquartered in Sunnyvale, CA.

Rambus Inc.

Rambus is trending due to concerns around its latest earnings report, which revealed a revenue miss despite beating EPS estimates. The community is focused on the company's guidance and the impact of higher income tax expenses on margins, while some believe Rambus's connection to Micron Technology ($MU) still makes it a worthwhile play in the memory market.

Project Nema is a research initiative enhancing AI memory and companionship by integrating the C. elegans neural connectome with a large language model (LLM). The LLM translates human language to interact with the worm's simulated brain, addressing LLMs' lack of persistent emotional or psychological states beyond context windows. This creates a stable, evolving neural state that retains history across sessions. For example, user inputs like "good morning Nema" fetch state and history for processing. Utilities include companionship, where Nema acts as the LLM's "soul" for long-term personality building, and dynamic adaptation mimicking life. It also aims to boost LLM outputs via extended memory. The project involves user management and visualizations.

NEMA LAB

NEMA CRYPTO is trending as the community discusses its potential utility and recent price action, with some excitement around the upcoming Worminal launch. Some users are pointing to NEMA's AI brain tech and comparing it to the previous performance of $WORM, while others express concerns about potential issues.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield

GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update

Ongoing Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) with interim data expected H1 2024 and topline data expected H2 2024...

GRI Bio sees cash runway into 3Q24

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

GRI Bio reports 2023 EPS ($28.25) vs. ($24.95) last year

GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference

Live webcast on Wednesday, April 3rd at 10:10 AM ET LA JOLLA, CA, March 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) ( GRI Bio or the Company ), a biotechnology company advancing...

GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators

Company advancing an innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases Ongoing efforts to build a robust global patent estate for a...

GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom

MHRA authorization expands ongoing U.S. Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis ( IPF ) with interim data expected H1 2024 and...

Short Interest in GRI Bio, Inc. (NASDAQ:GRI) Declines By 64.7%

GRI Bio, Inc. (NASDAQ:GRI  Get Free Report) was the recipient of a significant drop in short interest in February. As of February 15th, there was short interest totalling 18,600 shares, a...

GRI Bio (NASDAQ:GRI) versus BioMarin Pharmaceutical (NASDAQ:BMRN) Head to Head Comparison

GRI Bio (NASDAQ:GRI  Get Free Report) and BioMarin Pharmaceutical (NASDAQ:BMRN  Get Free Report) are both medical companies, but which is the better business? We will compare the two...

GRI Bio prices 5M shares at $1.10 in public offering

GRI Bio prices 5M shares at $1.10 in public offering...

GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded by Vipin Kumar Chaturvedi in May 2009 and is headquartered in La Jolla, CA.

GRI Bio Inc

Will Alphabet ($GOOGL) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Alphabet Inc Class A

) beat quarterly earnings? 
 
*Powered by Polymarket

GRI
GRI Bio Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest GRI News

GRIGRI Bio Inc